CH553200A - Verfahren zur herstellung von virostatisch wirksamen neuen (alpha)-carbolinen. - Google Patents

Verfahren zur herstellung von virostatisch wirksamen neuen (alpha)-carbolinen.

Info

Publication number
CH553200A
CH553200A CH389969A CH389969A CH553200A CH 553200 A CH553200 A CH 553200A CH 389969 A CH389969 A CH 389969A CH 389969 A CH389969 A CH 389969A CH 553200 A CH553200 A CH 553200A
Authority
CH
Switzerland
Prior art keywords
virostatically
carbolines
alpha
producing
effective new
Prior art date
Application number
CH389969A
Other languages
German (de)
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Priority to CH1876371A priority Critical patent/CH536848A/de
Priority to CH1876271A priority patent/CH536847A/de
Publication of CH553200A publication Critical patent/CH553200A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
CH389969A 1968-03-15 1969-03-14 Verfahren zur herstellung von virostatisch wirksamen neuen (alpha)-carbolinen. CH553200A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH1876371A CH536848A (de) 1968-03-15 1969-03-14 Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen
CH1876271A CH536847A (de) 1968-03-15 1969-03-14 Verfahren zur Herstellung von virostatisch wirksamen neuen a-Carbolinen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1273068 1968-03-15
GB1273168A GB1268772A (en) 1968-03-15 1968-03-15 NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME

Publications (1)

Publication Number Publication Date
CH553200A true CH553200A (de) 1974-08-30

Family

ID=26249226

Family Applications (2)

Application Number Title Priority Date Filing Date
CH389969A CH553200A (de) 1968-03-15 1969-03-14 Verfahren zur herstellung von virostatisch wirksamen neuen (alpha)-carbolinen.
CH1271771A CH561206A5 (enExample) 1968-03-15 1969-03-14

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1271771A CH561206A5 (enExample) 1968-03-15 1969-03-14

Country Status (8)

Country Link
AT (2) AT304533B (enExample)
BE (1) BE729855A (enExample)
CH (2) CH553200A (enExample)
DE (1) DE1913119A1 (enExample)
FR (1) FR2003999A1 (enExample)
GB (1) GB1268772A (enExample)
IE (1) IE32705B1 (enExample)
NL (1) NL6903973A (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7605398L (sv) * 1975-05-28 1976-11-29 Merck & Co Inc 3h-1,2,3-trizol(4,5-b)pyridiner
US4000286A (en) 1975-05-28 1976-12-28 Merck & Co., Inc. 3-Phenyl,3H 1,2,3 triazolo[4,5-b]pyridines
JPS5536401A (en) * 1978-06-09 1980-03-14 Japan Tobacco Inc Amino-alpha-carboline compound and mutagenic agent containing the same
FR2428642A1 (fr) * 1978-06-15 1980-01-11 Sumitomo Chemical Co Derives indolo-isoquinoleiniques
US4558132A (en) * 1982-07-02 1985-12-10 A. H. Robins Company, Incorporated Nitro, amino and aroylamino-N-phenylpyridinamines in a process for preparing pyrido[1,4]benzodiazepines
USRE37525E1 (en) 1991-05-01 2002-01-22 Henry M. Jackson Foundation Method for treating infectious respiratory diseases
AU675932B2 (en) * 1992-04-03 1997-02-27 Pharmacia & Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
US5369086A (en) * 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
US5783575A (en) * 1994-03-14 1998-07-21 Novo Nordisk A/S Antagonists, their preparation and use
WO1997005137A1 (en) * 1995-07-31 1997-02-13 Novo Nordisk A/S Heterocyclic compounds, their preparation and use
CA2396560A1 (en) * 2000-01-07 2001-07-19 Warner-Lambert Company Tricyclic compounds and method of treating herpes virus
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7064139B2 (en) * 2001-10-29 2006-06-20 Uniroyal Chemical Company, Inc. Method for treating retroviral infections
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2869316B1 (fr) * 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
EP2161271A1 (en) 2008-09-08 2010-03-10 Università Degli Studi Di Milano - Bicocca Alpha-carboline inhibitors of NMP-ALK, RET, and Bcr-Abl
EP3915987B1 (en) 2013-03-14 2023-12-13 Osteoqc Inc. Alkyl-amine harmine derivatives for promoting bone growth
WO2015110263A1 (en) * 2014-01-21 2015-07-30 Ac Immune Sa Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyolid-like proteins
AU2019321434B2 (en) 2018-08-14 2025-05-08 Ossifi Therapeutics Llc Pyrrolo - dipyridine compounds
EP3837241A4 (en) 2018-08-14 2022-05-18 Osteoqc Inc. FLUOROUS SS CARBOLINE COMPOUNDS
FR3109534B1 (fr) 2020-04-22 2022-03-25 Soprema Installation et procédé de traitement de produits composites à base de matières thermoplastiques

Also Published As

Publication number Publication date
IE32705B1 (en) 1973-10-31
IE32705L (en) 1969-09-15
GB1268772A (en) 1972-03-29
CH561206A5 (enExample) 1975-04-30
FR2003999A1 (enExample) 1969-11-14
NL6903973A (enExample) 1969-09-17
AT304533B (de) 1973-01-10
BE729855A (enExample) 1969-09-15
DE1913119A1 (de) 1970-08-06
AT310155B (de) 1973-09-25

Similar Documents

Publication Publication Date Title
CH553200A (de) Verfahren zur herstellung von virostatisch wirksamen neuen (alpha)-carbolinen.
CH554877A (de) Verfahren zur herstellung von neuen chinazolinon- bzw. chinazolinthionderivaten.
CH556322A (de) Verfahren zur herstellung von neuen naphthylalkylaminen.
CH549599A (de) Verfahren zur herstellung von neuen 5-nitrofuranderivaten.
CH558349A (de) Verfahren zur herstellung von furan-3-carboxamiden.
CH558342A (de) Verfahren zur herstellung von neuen phenolderivaten.
CH547819A (de) Verfahren zur herstellung von isothiazolderiavaten.
CH547284A (de) Verfahren zur herstellung von 1-hydroxy-2-pyridonen.
CH551957A (de) Verfahren zur herstellung von neuen jononderivaten.
CH558794A (de) Verfahren zur herstellung von 3-aroylpyrrolidinen.
CH508616A (de) Verfahren zur Herstellung von 2-Alkyl-3-hydroxy-4,5-dihydrofuran-4-onen
CH551991A (de) Verfahren zur herstellung von azacarbazolen.
AT294105B (de) Verfahren zur Herstellung von neuen 2-Hydroxymethyl-3-carbonsäureamido-chinoxalin-di-N-oxyden(1,4)
CH555366A (de) Verfahren zur herstellung von 3-aza-a-homo-steroide.
CH548979A (de) Verfahren zur herstellung von chalconderivaten.
CH525876A (de) Verfahren zur Herstellung von 3-Keto-6,7-methylen-20-spirox-4-enen
CH556857A (de) Verfahren zur herstellung von 1-azacyclo-4-imino-1,4dihydropyridinen.
AT293417B (de) Verfahren zur herstellung von neuen n-glycidyl-glykolurilen
AT288359B (de) Verfahren zur herstellung von neuen alpha, beta-diphenylacylophenonen
CH550202A (de) Verfahren zur herstellung von neuen cephalosporinverbindungen.
AT285586B (de) Verfahren zur herstellung von diaethyl-3,4-dialkoxyanilinomethylenmalonaten
CH557798A (de) Verfahren zur herstellung von enaminketonen.
CH553753A (de) Verfahren zur herstellung von neuen amidinen.
CH517088A (de) Verfahren zur Herstellung von 3B,14BB-Dihydroxy-carda-4,20(22)-dienoliden
CH557326A (de) Verfahren zur herstellung von neuen 1-aminoalkylidenbenzocycloalkan-2-spiro-cycloaliphatischen verbindungen.

Legal Events

Date Code Title Description
PL Patent ceased